Monogram Biosciences Revenue and Competitors

Location

$65M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Monogram Biosciences's estimated annual revenue is currently $48.6M per year.(i)
  • Monogram Biosciences's estimated revenue per employee is $193,750
  • Monogram Biosciences's total funding is $65M.

Employee Data

  • Monogram Biosciences has 251 Employees.(i)
  • Monogram Biosciences grew their employee count by -4% last year.

Monogram Biosciences's People

NameTitleEmail/Phone
1
Associate VP, Medical Affairs and EducationReveal Email/Phone
2
Associate VP, Technical Director, R&DReveal Email/Phone
3
Associate VP, OperationsReveal Email/Phone
4
Director QualityReveal Email/Phone
5
Director, Virology R&DReveal Email/Phone
6
Director Oncology R&D; Director Technology TransferReveal Email/Phone
7
Associate DirectorReveal Email/Phone
8
Director Lab OperationsReveal Email/Phone
9
Project DirectorReveal Email/Phone
10
Director OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Monogram Biosciences?

ViroLogic is a biotechnology company advancing individualized medicine and pharmacogenomics by discovering, developing and marketing innovative products to guide and improve treatment of serious viral diseases such as AIDS and hepatitis. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines targeted at emerging drug-resistant viruses.

keywords:N/A

$65M

Total Funding

251

Number of Employees

$48.6M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Monogram Biosciences News

2022-04-13 - Prolonged viral suppression with anti-HIV-1 antibody therapy

... 3BNC117 by the PhenoSense Monoclonal Antibody Assay (Labcorp-Monogram Biosciences) with an exploratory susceptibility threshold (Fig.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$147.3M261-2%$192.5M
#2
$95.1M2625%N/A
#3
$197.9M266-11%$194.5M
#4
$29.7M2707%N/A
#5
$10.1M300-13%N/A